Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort)
Claire Noé, Julie Henriques, Brice Chanez, Déwi Vernerey et autres
0 citationsJHEP Reports
Julie Henriques
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
137Publications signalées
1885Citations signalées
7Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesGenetic factors in colorectal cancerPancreatic and Hepatic Oncology ResearchBreast Cancer Treatment Studies
Publications récentes
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma: Long-term follow-up of the GERCOR NEONIPIGA phase II study.
Thomas Samaille, Julie Henriques, David Tougeron, Guillaume Piessen et autres
1 citationJournal of Clinical Oncology
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study
Constance Thibault, Mostefa Bennamoun, Aude Fléchon, Gwénaëlle Gravis et autres
0 citationsJournal of Clinical Oncology
Dual CTLA-4/PD-1 Blockade Versus Anti–PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors
Léa Jehanno, Julie Henriques, Thomas Samaille, Camille Loisel et autres
0 citationsClinical Colorectal Cancer
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer
Benoist Chibaudel, Louis-Marie Dourthe, Thierry André, Julie Henriques et autres
0 citationsSignal Transduction and Targeted Therapy
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO
Émeric Boisteau, Alice Boilève, D. Tougeron, Dewi Vernerey et autres
0 citationsEuropean Journal of Cancer
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting Stoma
A Marqués, Julie Henriques, D. Vernerey, Y. Parc et autres
0 citationsJCO Oncology Practice
Activated Protein C Sensitivity Assessed with Thrombin Generation Assay in Antiphospholipid Syndrome Women: Results from Two French Cohorts
Thomas Foret, V. Dufrost, Jeremy Lagrange, Véronique Regnault et autres
0 citationsThrombosis and Haemostasis
ALTOPANC: Local ablative therapies in oligometastatic pancreatic adenocarcinoma—A bi-national French-Belgian retrospective study.
Pauline Parent, Victoria Pacquement, Alice Boilève, Julie Henriques et autres
1 citationJournal of Clinical Oncology
Interpreting the pT1 subgroup in the ASTER 70s trial – Authors' reply
E. Brain, F. Rollot-Trad, Telma Roques, Julie Henriques et autres
0 citationsThe Lancet
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO
Émeric Boisteau, Alice Boilève, David Tougeron, Dewi Vernerey et autres
0 citationsSSRN Electronic Journal
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study].
Étienne Brain, Florence Rollot-Trad, Godelieve Rochette de Lempdes, Michaël Bringuier et autres
0 citationsPubMed
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.